您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > CaCCinh-A01
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
CaCCinh-A01
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CaCCinh-A01图片
CAS NO:407587-33-1
规格:≥98%
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议

产品介绍
理化性质和储存条件
Molecular Weight (MW) 347.43
Formula C18H21NO4S
CAS No. 407587-33-1
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 10 mM in DMSO
Water: <1 mg/mL
Ethanol:
SMILES Code O=C(C1=C(NC(C2=CC=CO2)=O)SC3=C1CCC(C(C)(C)C)C3)O
Synonyms CaCC(inh)-A01; CaCCinh-A01; TMEM16 Blocker I.
实验参考方法
In Vitro

In vitro activity: CaCCinh-A01 (also known as TMEM16 Blocker I) is an inhibitor of TMEM16A and calcium-activated chloride channel (CaCC) with IC50s of 2.1 and 10 μM, respectively. TMEM16A (ANO1) functions as a calcium-activated chloride channel (CaCC). CaCCs are widely expressed in mammalian tissues, including intestinal epithelia, where they facilitate fluid secretion. CaCCinh-A01 is a non-selective inhibitor of CaCCs that blocks ATP-stimulated chloride conductance in human salivary gland, intestinal, and bronchial epithelium (mean IC50 = 10 μM). As a TMEM16A/CaCC inhibitor, CaCCinh-A01 is a potential development candidate for drug therapy of hypertension, pain, diarrhea, and excessive mucus production. 3


Kinase Assay: CaCCinh-A01 (also known as TMEM16 Blocker I) is an inhibitor of TMEM16A and calcium-activated chloride channel (CaCC) with IC50s of 2.1 and 10 μM, respectively. 0 μM CaCCinh-A01 and 100 μM tannic acid strongly inhibit CaCC current following ATP stimulation. Calcium-dependent chloride current is reduced by 38±14, 66±10, and 91±1% by 0.1, 1, and 10 μM CaCCinh-A01, respectively. ATP-induced short-circuit currents are reduced by 38±7 and 78±3% at 10 and 30 μM CaCCinh-A01, respectively.


Cell Assay: Each well of a 96-well plate is washed three times with PBS (200 μL/wash), leaving 50 μL of PBS. Test compounds (including CaCCinh-A01) (0.5 μL) are added to each well at 25 μM final concentration. After 10 min, 96-well plates are transferred to a plate reader for fluorescence assay. Each well is assayed individually for TMEM16A-mediated I- influx by recording fluorescence continuously (400 ms/point) for 2 s (base line), then 50 μL of a 140 mM I- solution containing 200 μM ATP is added. The initial rate of I- influx is computed from fluorescence data by nonlinear regression.

In Vivo
Animal model
Formulation & Dosage
References J Biol Chem. 2011 Jan 21;286(3):2365-74. Mol Pharmacol. 2008 Mar;73(3):758-68. Epub 2007 Dec 14.